---
layout: post
title: 辉瑞新的RSV疫苗获批
date: 2023-06-01 08:33:04.000000000 +08:00
link: https://cn.wsj.com/amp/articles/%E8%BE%89%E7%91%9E%E6%96%B0%E7%9A%84rsv%E7%96%AB%E8%8B%97%E8%8E%B7%E6%89%B9-80b08d15
categories: wsj
---

<main id="main" role="main">
<div>


</div>
<div itemprop="articleLead" data-sbId="CN-BIZ-20230601081759">
    <div>
      <div class="media-object scope-
          header
">
          <figure>
      <div>
        <img
          srcset="https://images.wsj.net/im-790884?width=540&amp;size=1.5023474178403755 540w, https://images.wsj.net/im-790884?width=620&amp;size=1.5023474178403755 620w, https://images.wsj.net/im-790884?width=639&amp;size=1.5023474178403755 639w, https://images.wsj.net/im-790884?width=860&amp;size=1.5023474178403755 860w, https://images.wsj.net/im-790884?width=860&amp;size=1.5023474178403755&amp;pixel_ratio=1.5 1290w, https://images.wsj.net/im-790884?width=860&amp;size=1.5023474178403755&amp;pixel_ratio=2 1720w, https://images.wsj.net/im-790884?width=860&amp;size=1.5023474178403755&amp;pixel_ratio=3 2580w"
          src="https://images.wsj.net/im-790884?width=860&amp;height=572"
          layout="responsive"
          placeholder
          alt="">
        </img>
      </div>
      <figcaption>
        <p>图为蒙大拿州州长Greg Gianforte两年前接受一剂疫苗。据调查和健康专家称，新冠大流行改变了许多人对疫苗接种的态度。</p>
    <p> 图片来源：Thom Bridge/Independent Record/Associated Press</p>
  </figcaption>
</figure>

      </div>
    </div>
</div>
<div data-sbId="CN-BIZ-20230601081759">

<div>

  <div>
      <p> </p>
              <p><span itemprop="name">
                <a href="https://www.wsj.com/news/author/jared-s-hopkins" itemprop="url" rel="author">Jared S. Hopkins</a>
              </span></p>

  </div>
    <time>
      2023年6月1日08:25 CST 更新
    </time>
</div>

<div subscriptions-actions subscriptions-display="NOT data.noSharing">
  <div>
    <social-share type="system" width="72" height="24"
      data-param-url="https://cn.wsj.com/articles/辉瑞新的rsv疫苗获批-80b08d15">
    </social-share>
  </div>
</div>


<div subscriptions-section="content">
</div>
<div subscriptions-section="content-not-granted">
</div>



<section subscriptions-section="content">
      <p>疫苗制造商正面临一个新冠疫情后的难题：新的疫苗针对越来越多的疾病，但人们比以往任何时候都更加怀疑疫苗的有效性。</p>
      <p>辉瑞公司(Pfizer Inc., PFE)针对致命呼吸道病毒RSV的最新疫苗于周三在美国获得批准。在此之前，葛兰素史克(GSK PLC, GSK)的首支RSV疫苗本月早些时候获批，默克公司(Merck &amp; Co. Inc., MRK)的一款肺炎疫苗去年也获得批准。与此同时，针对艾滋病毒、莱姆病和其他病原体的新疫苗正在研制中。</p>
      <p>美国食品药品管理局(Food and Drug Administration, 简称FDA)批准了辉瑞公司名为Abrysvo的疫苗，用于预防60岁及以上人群由RSV引起的肺炎和支气管炎等下呼吸道疾病。</p>
      <p>FDA还在审查是否批准辉瑞公司的疫苗在孕妇中使用，以保护新生儿在生命的最初几个月免受RSV感染。</p>
      <div> <p>除了辉瑞和葛兰素史克，Moderna Inc. (MRNA)和Bavarian Nordic (BVNRY)也在研发RSV疫苗。Jefferies分析师Michael Yee表示，RSV疫苗全球每年的销售额可能达到150亿美元。</p>
      </div>
</section>

</div>
      </main>
